Trial Profile
Effect of Exenatide Once Weekly on Cardiovascular Risk Markers in Patients With Type-2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results assessing effects of exenatide LAR on cardio-metabolic parameters presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results investigating whether exenatide LAR exert different effects on several cardio-metabolic parameters in obese vs. non-obese T2DM patients presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes